1. Trial of Solanezumab in Preclinical Alzheimer’s Disease
2. ClinicalTrials. Gov clinical trial of solanezumab for older individuals who may be at risk of memory loss (A4). [cited 2023 Nov 19]. Available from: https://clinicaltrials.gov/study/NCT02008357?term=SOLANEZUMAB&rank=6
3. Mayo Clinic. Alzheimer’s disease. [cited 2023 Dec 19]. Available from: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
4. Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns
5. U.S. Food & Drug Administration. FDA grants accelerated approval for Alzheimer’s drug. [cited 2023 Dec 19]. Available from: https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug